Xanaflu

Xanaflu is an inactivated quadrivalent influenza vaccine designed to protect against four influenza virus strains, including influenza A and B. It is administered via intramuscular or subcutaneous injection to help reduce the risk of seasonal flu. This vaccine is suitable for adults and children, providing broad protection against common flu variants.

Xanaflu is used to help prevent influenza, commonly known as the flu. It targets four key virus strains, including two influenza A and two influenza B types, to provide broad seasonal coverage. The vaccine is intended for individuals seeking protection from flu symptoms and complications. It is particularly recommended for those at higher risk of flu-related health issues.

After receiving Xanaflu, the body’s immune system produces antibodies to fight off influenza viruses. This process may result in mild side effects such as soreness at the injection site or mild flu-like symptoms. These effects are typically temporary and indicate the vaccine is working to build immunity.

Xanaflu should be stored refrigerated between 2°C and 8°C and protected from light. It is important to check the vaccine vial for any discoloration or particles before use. Individuals with severe allergies to any component of the vaccine should consult a healthcare provider before administration.

Xanaflu may interact with immunosuppressive therapies, reducing its effectiveness. Concurrent use with other vaccines should be spaced appropriately to avoid overlapping side effects. Always inform your healthcare provider about any medications or treatments you are currently receiving.